No in vivo GLP tox; GLP human tissue cross-reactivity (42 tissues); non-GLP NALM-6 NSG xenograft, single IV dose, Day 16
“The GLP tissue cross-reactivity study was conducted to determine potential binding of 1 or 3 μg/mL CAT19 to 42 normal human tissues and blood smears.”